Picture of Surrozen logo

SRZN Surrozen Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for Surrozen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-54.6-36-43-63.6-242
Depreciation
Non-Cash Items3.99-1.684.745.3208
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-0.221-8.42-3.93-0.8363.15
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-48.8-44.1-40.4-17.6-30.2
Capital Expenditures-1.27-0.728-0.398-0.026-0.128
Purchase of Fixed Assets
Other Investing Cash Flow Items-76.43952.10
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-77.738.351.7-0.026-0.128
Financing Cash Flow Items-0.0040
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities125-2.560.27616.285.1
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.89-8.411.6-1.4854.7